Insights

The Medibank (ASX:MPL) share price is now trading on a forecast 3.76% fully franked dividend yield

Is it worth buying the health insurance company’s shares for its dividend?
The post The Medibank (ASX:MPL) share price is now trading on a forecast 3.76% fully franked dividend yield appeared first on The Motley Fool Australia. –

The Medibank Private Ltd (ASX: MPL) share price has travelled 20% higher over the past year. This comes as the private health insurance giant has enjoyed improved trading conditions within the industry.

This morning, Medibank shares were touching a new 52-week high of $3.45, up 1.17%. However, they have partially retreated are now trading hands at $3.42, a gain of 0.29% on yesterday’s closing price.

Why is the Medibank share price pushing higher?

Investors are pushing up the Medibank share price despite no news coming from the company since its last release in late June.

According to the update, Medibank returned roughly $105 million in COVID-19 savings to customers through premium relief. The latest financial support package has boosted the company’s reputation in becoming socially responsible.

Medibank CEO David Koczkar commented:

We said right from the start of the pandemic that we would not profit from COVID-19, and that we were committed to returning any COVID-19 savings back to our customers because it is the right thing to do. And today’s announcement shows that we have done what we said we would.

The Medibank share price jumped into the green on the news.

Furthermore, Medibank advised that the give-back program is not expected to impact its operating earnings for the 2021 financial year.

One broker who retained its outperform rating was leading financial services company, Credit Suisse. The agency raised its price target for Medibank shares to $3.50 on the back of increased earnings estimates for FY21.

How much is Medibank forecasted to pay in dividends?

With the company scheduled to report its full-year results on 25 August, investors may be wondering about the dividend payments.

Medibank paid a fully franked dividend of 5.8 cents in March for H1 FY21, slightly below the 6.3 cents in the prior period.

However, Credit Suisse is forecasting a total FY21 dividend payment of 13 cents, implying a 7.2 cents per share dividend payment. This would give Medibank a current dividend yield of 3.76%. Not a bad return when including the strong Medibank share price rise.

The post The Medibank (ASX:MPL) share price is now trading on a forecast 3.76% fully franked dividend yield appeared first on The Motley Fool Australia.

Should you invest $1,000 in Medibank right now?

Before you consider Medibank, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Medibank wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of May 24th 2021

More reading

These 10 ASX 200 shares hit new 52-week highs this Monday

Should you buy Medibank (ASX:MPL) shares in July for the dividend?
The Medibank (ASX:MPL) share price just hit a new 52-week high
Top brokers name 2 ASX dividend shares to buy today

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!